21 Sep 2026
Partners Michael Resch and Smitha Stansbury Join Sidley Austin
"Michael Resch and Smitha Stansbury join Sidley Austin to bolster its life sciences capabilities; Resch joins the Litigation group (food, beverage, supplements, CPG) and Stansbury joins the Food, Drug & Medical Device practice (FDA regulatory)."
Michael Resch joins Sidley as a partner in the Litigation group. His practice focuses on complex civil litigation and investigations, emphasizing food and beverage, dietary supplements, and consumer packaged goods, often at the intersection of litigation and regulation. His experience includes false advertising and consumer class actions, matters involving alleged product contaminants, nutrition labeling, ingredient and marketing claims, consumer deception, and matters involving the FDA, USDA and the National Organic Program, as well as other complex commercial disputes and investigations. He joins Sidley from King & Spalding LLP, where he was a partner in the FDA and Life Sciences practice.
Smitha Stansbury joins Sidley as a partner in the Food, Drug, and Medical Device practice in Washington, D.C. Her practice focuses on FDA regulatory matters for food and beverage, dietary supplement, and personal care product companies, including strategic regulatory counseling, FDA and USDA enforcement response (warning letters, seizures, recalls, and import detentions), and regulatory due diligence for M&A transactions. She is Band 1 ranked by Chambers USA (Nationwide) for Food & Beverages: Regulatory & Litigation. Ms. Stansbury joins Sidley from King & Spalding LLP, where she was a partner in the FDA and Life Sciences practice.